Glypican 3 is a sensitive, but not a specific, marker for the diagnosis of yolk sac tumours

Histopathology

Volumn 58, Issue 2, 2011, Pages 312-314

  Preda, Ovidiu ^a   Nicolae, Alina ^b   Aneiros Fernández, José ^b   Borda, Angela ^a   Nogales, Francisco F ^b  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; GLYPICAN 3;

EMBRYONAL CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEMINOMA; TERATOMA; TUMOR DIFFERENTIATION; YOLK SAC TUMOR;

ALPHA-FETOPROTEINS; ENDODERMAL SINUS TUMOR; GLYPICANS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; SENSITIVITY AND SPECIFICITY; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79951676500     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03735.x     Document Type: Letter

References (4)

1. Zynger DL, McCallum JC, Luan C et al. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns. Histopathology 2010; 56; 750-757.
2. Zynger DL, Dimov ND, Luan C et al. Glypican 3: a novel marker in testicular germ cell tumors. Am. J. Surg. Pathol. 2006; 30; 1570-1575.
3. Nogales FF, Talerman A, Kubik-Huch R et al. Ovarian germ cell tumours. In Tavassoli FA, Devilee P eds. WHO classification of tumours. III. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC, 2003; 165-167.
4. Aggarwal N, Parwani AV. Spermatocytic seminoma. Arch. Pathol. Lab. Med. 2009; 133; 1985-1988.